<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Utah Medical Products, Inc.

    Utah Medical Products, Inc.

    Utah Medical Products IncÂŽ, established in 1978, develops, manufactures and marke...

    Utah Medical Products IncÂŽ, established in 197...

    Filing Type:    PU
    Pulmatrix, Inc.

    Pulmatrix, Inc.

    Pulmatrix is a clinical stage biopharmaceutical company developing innovative inha...

    Pulmatrix is a clinical stage biopharmaceutical...

    Filing Type:    PU
    Tonix Pharmaceuticals Holding Corp.

    Tonix Pharmaceuticals Holding Corp.

    Tonix is a clinical-stage biopharmaceutical company focused on discovering and dev...

    Tonix is a clinical-stage biopharmaceutical com...

    Filing Type:    PU
    Phormed Inc

    Phormed Inc

    PhorMed is a clinical stage biopharmaceutical company located in Beverly Hills Cal...

    PhorMed is a clinical stage biopharmaceutical c...

    Amount Raised:    $128,700.00
    Fundraising Status:    EC
    Filing Type:    CF
    Rockwell Medical, Inc.

    Rockwell Medical, Inc.

    Rockwell Medical (NASDAQ: RMTI) is a fully-integrated biopharmaceutical company ta...

    Rockwell Medical (NASDAQ: RMTI) is a fully-inte...

    Filing Type:    PU
    Akcea Therapeutics, Inc.

    Akcea Therapeutics, Inc.

    Akcea Therapeutics is a development and commercialization company focused on helpi...

    Akcea Therapeutics is a development and commerc...

    Filing Type:    PU
    Curis, Inc.

    Curis, Inc.

    Curis is a biotechnology company focused on the development and commercialization ...

    Curis is a biotechnology company focused on the...

    Filing Type:    PU
    argenx SE

    argenx SE

    argenx is a clinical-stage biotechnology company developing a deep pipeline of dif...

    argenx is a clinical-stage biotechnology compan...

    Filing Type:    PU
    Aileron Therapeutics, Inc.

    Aileron Therapeutics, Inc.

    Aileron Therapeutics is a clinical stage company discovering and developing novel ...

    Aileron Therapeutics is a clinical stage compan...

    Filing Type:    PU
    Enlivex Therapeutics Ltd.

    Enlivex Therapeutics Ltd.

    Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug p...

    Enlivex is a clinical stage immunotherapy compa...

    Filing Type:    PU
    Theravance Biopharma, Inc.

    Theravance Biopharma, Inc.

    Theravance Biopharma is a diversified biopharmaceutical company with the core purp...

    Theravance Biopharma is a diversified biopharma...

    Filing Type:    PU
    Forward Pharma A/S

    Forward Pharma A/S

    Forward Pharma A/S is a Danish biopharmaceutical company that commenced developmen...

    Forward Pharma A/S is a Danish biopharmaceutica...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.